Acadia Healthcare Co. (NASDAQ:ACHC)‘s stock had its “outperform” rating reaffirmed by equities researchers at Leerink Swann in a research note issued to investors on Monday. They presently have a $80.00 price target on the stock. Leerink Swann’s price target would indicate a potential upside of 61.49% from the company’s previous close.
A number of other equities research analysts have also issued reports on the stock. Royal Bank Of Canada dropped their price objective on shares of Acadia Healthcare from $86.00 to $78.00 and set an “outperform” rating for the company in a report on Monday, August 1st. Jefferies Group reaffirmed a “buy” rating and set a $85.00 target price on shares of Acadia Healthcare in a research note on Monday, June 27th. RBC Capital Markets reaffirmed an “outperform” rating and set a $78.00 target price (down previously from $86.00) on shares of Acadia Healthcare in a research note on Monday, August 1st. Robert W. Baird lowered their target price on shares of Acadia Healthcare from $67.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, September 15th. Finally, Zacks Investment Research lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 11th. One research analyst has rated the stock with a sell rating and twelve have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $78.46.
Acadia Healthcare (NASDAQ:ACHC) opened at 49.12 on Monday. The stock has a market cap of $4.29 billion, a P/E ratio of 26.24 and a beta of 0.84. Acadia Healthcare has a 12 month low of $48.05 and a 12 month high of $74.77. The stock has a 50 day moving average of $51.46 and a 200-day moving average of $55.37.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Friday, July 29th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.73. Acadia Healthcare had a net margin of 6.44% and a return on equity of 9.35%. The firm earned $756.50 million during the quarter, compared to analyst estimates of $752.57 million. During the same quarter in the prior year, the firm posted $0.57 earnings per share. Acadia Healthcare’s quarterly revenue was up 66.8% on a year-over-year basis. On average, equities analysts forecast that Acadia Healthcare will post $2.64 EPS for the current fiscal year.
In other Acadia Healthcare news, major shareholder Waud Capital Partners Ii, L.L. sold 54,254 shares of the firm’s stock in a transaction that occurred on Tuesday, September 13th. The shares were sold at an average price of $51.71, for a total transaction of $2,805,474.34. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Reeve B. Waud sold 1,360,977 shares of the firm’s stock in a transaction that occurred on Friday, September 16th. The stock was sold at an average price of $48.52, for a total transaction of $66,034,604.04. Following the sale, the director now directly owns 55,673 shares in the company, valued at approximately $2,701,253.96. The disclosure for this sale can be found here. Company insiders own 17.20% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the company. American International Group Inc. raised its position in shares of Acadia Healthcare by 71.7% in the second quarter. American International Group Inc. now owns 2,218 shares of the company’s stock worth $123,000 after buying an additional 926 shares during the period. Advisor Group Inc. acquired a new position in shares of Acadia Healthcare during the second quarter worth about $166,000. Springbok Capital Management LLC raised its position in shares of Acadia Healthcare by 101.3% in the first quarter. Springbok Capital Management LLC now owns 3,741 shares of the company’s stock worth $206,000 after buying an additional 1,883 shares during the period. Jane Street Group LLC acquired a new position in shares of Acadia Healthcare during the second quarter worth about $210,000. Finally, Calvert Investment Management Inc. raised its position in shares of Acadia Healthcare by 0.9% in the second quarter. Calvert Investment Management Inc. now owns 4,192 shares of the company’s stock worth $232,000 after buying an additional 39 shares during the period.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Receive News & Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.